Nutex Health (NASDAQ:NUTX – Free Report) had its target price lifted by Maxim Group from $45.00 to $50.00 in a research report report published on Tuesday, Marketbeat reports. The firm currently has a buy rating on the stock.
Separately, Benchmark boosted their target price on Nutex Health from $30.00 to $45.00 and gave the stock a “buy” rating in a report on Wednesday, August 21st.
Get Our Latest Analysis on Nutex Health
Nutex Health Price Performance
Insider Buying and Selling
In other Nutex Health news, CFO Jon Christian Bates purchased 1,350 shares of the business’s stock in a transaction on Thursday, August 22nd. The stock was bought at an average cost of $21.46 per share, with a total value of $28,971.00. Following the acquisition, the chief financial officer now owns 2,277 shares of the company’s stock, valued at $48,864.42. The trade was a 100.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. 38.52% of the stock is owned by corporate insiders.
Institutional Trading of Nutex Health
Large investors have recently added to or reduced their stakes in the business. Essex Investment Management Co. LLC bought a new position in shares of Nutex Health during the 3rd quarter valued at $1,579,000. Thompson Davis & CO. Inc. acquired a new position in Nutex Health during the third quarter worth $494,000. Finally, International Assets Investment Management LLC bought a new position in Nutex Health during the third quarter valued at about $188,000. 5.32% of the stock is owned by institutional investors.
About Nutex Health
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
Read More
- Five stocks we like better than Nutex Health
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Learn Technical Analysis Skills to Master the Stock Market
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- What is MarketRankā¢? How to Use it
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.